BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 18042080)

  • 1. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
    Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
    Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
    Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
    Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
    Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
    Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
    Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Fenollar F; Goncalves A; Esterni B; Azza S; Habib G; Borg JP; Raoult D
    J Infect Dis; 2006 Nov; 194(10):1356-66. PubMed ID: 17054064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
    Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
    Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.